Suzanne Fleming

Suzanne Fleming

Plus aucun poste en cours
65 ans
Health Technology
Commercial Services
Finance

Profil

Suzanne Fleming is currently the Chief Accounting Officer at Beam Therapeutics, Inc. She previously held positions as the Senior Director-Finance at TransForm Pharmaceuticals, Inc. from 2003 to 2005, Principal at Transkaryotic Therapies, Inc., Principal at Oculon Corp from 1991 to 1995, Principal at CytoTherapuetics, Inc. from 1995 to 1998, Vice President-Finance at AVEO Pharmaceuticals, Inc. from 2005 to 2013, Treasurer, Chief Financial & Accounting Officer at Epizyme, Inc. from 2017 to 2019, and Vice President-Finance at Foundation Medicine, Inc. from 2014 to 2017.
She obtained her undergraduate degree from Stonehill College, Inc.

Anciens postes connus de Suzanne Fleming

SociétésPosteFin
EPIZYME, INC. Directeur Financier/CFO 31/01/2019
FOUNDATION MEDICINE INC Corporate Officer/Principal 01/09/2017
AVEO PHARMACEUTICALS, INC. Directeur Financier/CFO 05/04/2011
Directeur Financier/CFO 01/01/2005
Corporate Officer/Principal 01/01/1998
Voir l'expérience en détail de Suzanne Fleming

Formation de Suzanne Fleming

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

66

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Commercial Services

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

  1. Bourse
  2. Insiders
  3. Suzanne Fleming
-40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT